TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Immunotech Biopharm Ltd ( (HK:6978) ) is now available.
Immunotech Biopharm Ltd announced the resignation of Dr. Wang from her roles as Executive Director, CEO, and CTO due to disagreements with the Board. The company clarified that the disagreements were related to internal control enhancements and governance practices, which they believe do not infringe upon Dr. Wang’s authority or the company’s operational integrity. The Board maintains that Dr. Wang’s allegations are unfounded and assures stakeholders of continued adherence to corporate governance standards.
More about Immunotech Biopharm Ltd
Immunotech Biopharm Ltd is a biotechnology company incorporated in the Cayman Islands, focusing on the development and commercialization of innovative biopharmaceutical products. The company is listed on the Hong Kong Stock Exchange and is involved in the research and production of advanced medical treatments.
Average Trading Volume: 411,933
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$1.54B
Learn more about 6978 stock on TipRanks’ Stock Analysis page.